Regeneron PharmaceuticalsREGN 
$714.47-0.09%24h
-0.09%24h
Global rank201
Market cap$76.54B
Change 7d-2.82%
YTD Performance-
SP500 benchmark
P/E0
P/S5.84
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals REGN Earnings
Earnings in 2024: $3.95B
According to Regeneron Pharmaceuticals latest financial reports the company had earnings of $3.95B in 2023-12-31, an decrease of -8.87% to 2023.
Regeneron Pharmaceuticals Earnings History from 2020 to 2025
-
Value:-
Regeneron Pharmaceuticals Annual Earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | $3.95B | -8.87% |
| 2022 | $4.34B | -46.28% |
| 2021 | $8.08B | 129.86% |
| 2020 | $3.51B | - |
View the top earning stocks 
